SEELOS THERAPEUTICS, INC.
Industry: Biotechnology (See others in industry)
Address:
300 Park Avenue 2 Nd Floor
New York, NY, 10022
Phone: (646) 293-2100
New York, NY, 10022
Phone: (646) 293-2100
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-07-30 | New | $0 | $0 | Other | 06b | SEC link |
| 2024-05-31 | New | $0 | $0 | Other | 06b | SEC link |
| 2024-02-14 | New | $0 | $0 | Other | 06b | SEC link |
| 2020-09-14 | New | $0 | $0 | Other | 06b | SEC link |
| 2019-08-30 | New | $0 | $0 | Other | 06b | SEC link |
| 2017-09-27 | New | $3,691,000 | $3,691,000 | Equity Only | 06c | SEC link |
| 2016-10-13 | New | $3,653,106 | $3,653,106 | Other | 06c | SEC link |
| 2010-03-18 | New | $4,000,000 | $4,000,000 | Debt Only | 06 | SEC link |
| 2010-03-10 | New | $2,300,000 | $2,300,000 | Debt Only | 06 | SEC link |
| 2007-01-05 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2006-02-10 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2005-05-27 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2005-01-04 | Paper Filing | Unknown | Unknown | Other | Not Available |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Richard Berman | Director |
| Catherine Bovenizer | Executive |
| Edward Cox | Executive |
| Roberto Crea | Director |
| Margaret Dalesandro | Director |
| Bassam B. Damaj | Director, Executive |
| Brian Dorsey | Executive |
| Judith Dunn | Director |
| Henry J. Esber | Director, Executive |
| Michael Golembiewski | Executive |
| Brian Lian | Director |
| Vivian Liu | Director, Executive |
| Paul V. Maier | Director |
| Raj Mehra | Executive |
| Neil Morton | Executive |
| Daniel J. O'connor | Director |
| Leonard A Oppenheim | Director |
| Richard W. Pascoe | Director |
| Rusty Ray | Director |
| Sandford D. Smith | Director |
| Robin L. Smith | Director |
| Mark Westgate | Executive |
| Wendell Wierenga | Director |
| Kleanthis G. Xanthopoulos | Director |